Cargando…
Immune thrombocytopenia in a patient with COVID-19
This case report describes immune thrombocytopenic purpura in a 41-year-old man hospitalized in the intensive-care unit for COVID-19, 13 days after the onset of COVID-19 symptoms with respiratory failure at admission. Acute respiratory distress syndrome was treated with, among other drugs, low-molec...
Autores principales: | Deruelle, Emilie, Ben Hadj Salem, Omar, Sep Hieng, Sonnthida, Pichereau, Claire, Outin, Hervé, Jamme, Matthieu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365304/ https://www.ncbi.nlm.nih.gov/pubmed/32677007 http://dx.doi.org/10.1007/s12185-020-02943-5 |
Ejemplares similares
-
Risk Factors of AKI in Acute Respiratory Distress Syndrome: A
Time-Dependent Competing Risk Analysis on Severe COVID-19
Patients
por: Marchiset, Antoine, et al.
Publicado: (2023) -
Myocarditis, paraparesia and ARDS associated to COVID-19 infection
por: Jeantin, Lina, et al.
Publicado: (2021) -
Is fluid resuscitation the “Keyser Soze” of acute kidney injury in trauma patients?
por: Jamme, Matthieu, et al.
Publicado: (2019) -
Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
por: Fueyo-Rodriguez, Omar, et al.
Publicado: (2021) -
Immune Thrombocytopenia following COVID-19 Vaccine
por: Prasad, Sonal, et al.
Publicado: (2022)